Aminoleban EN Dosage/Direction for Use

Usually for adults, reconstitute one package (50 g) of AMINOLEBAN EN powder in about 180 mL of water or warm water (approximately 200 kcal/200 mL) and ingest with meals three times a day. The dosage may be adjusted according to the age of the patient and symptoms.
The regular daily dosage (150 g) of AMINOLEBAN EN powder provides 40.5 g of protein and a total of 639 kcal. When the patient needs more protein and calories, the balance should be supplemented in the patient's diet.
When a patient rejects AMINOLEBAN EN powder due to its taste, the concentration of the reconstituted product may be reduced to approximately 0.8 kcal/mL (reconstitute one package [50 g] of AMINOLEBAN EN powder in approximately 230 mL of water or warm water).
When a patient requires restriction of water intake, the concentration of the reconstituted product may be increased to approximately 2 kcal/mL (reconstitute one package [50 g] of AMINOLEBAN EN powder in approximately 80 mL of water or warm water).
The appropriate dosage of AMINOLEBAN EN powder should be established based on sufficient confirmation of each individual patient's current treatment status, including dietary therapy.
Switching from a low-protein diet (40 g/day of protein, 1600 kcal/day): Treatment should be switched to a combination of a low-protein diet (40 g/day of protein, 1000 kcal/day) and 3 packages/day of AMINOLEBAN EN powder (40.5 g/day of protein, 639 kcal/day).
Switching from therapy with an amino acid injection for hepatic encephalopathy: Treatment should be switched to a combination of a low-protein diet (40 g/day of protein, 1000 kcal/day) and 3 packages/day of AMINOLEBAN EN powder (40.5 g/day of protein, 639 kcal/day).
Switching from a conventional liver disease diet (80 g/day of protein, 2100 kcal/day): Treatment should be switched to a combination of a low-protein diet (40 g/day of protein, 1500 kcal/day) and 3 packages/day of AMINOLEBAN EN powder (40.5 g/day of protein, 639 kcal/day).
Route of administration: AMINOLEBAN EN powder is intended for oral feeding and should not be administered into a blood vessel.